Abstract
Adaptive T-cell responses to treatment. T-cell function was assessed by ELISpot assay, which showed an IFNγ-release response to CEA and TG6002. A, Data expressed as the mean fold change ± SEM SFU of post-treatment samples compared with baseline. n = 6 patients, sample availability–dependent. B, Representative examples of SFU from two patients showing BS and post-treatment samples, in triplicate, depicting responses to CEA and TG6002. C and D, TCRβ sequencing examined the T-cell clonal response to TG6002 infusion. CDR3 sequences were matched to known TCRs using the McPAS database. TCRs matched to cancer antigen epitopes (C) and neoantigen epitopes (D) are shown; data are expressed as number of total matched TCRs (x-axis) vs. the sum of productive frequencies of matched TCRs (y-axis). Cohort 1; purple, cohort 2: green, and cohort 3: blue. SFU, spot-forming units; CDR3, complementary-determining region 3; BS, baseline.